Aclaris Therapeutics, Inc. (ACRS) vs BlossomHill Therapeutics, Inc. (BLSM)
A side-by-side comparison of Aclaris Therapeutics, Inc. and BlossomHill Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRS
Aclaris Therapeutics, Inc.
$4.11HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
BLSM
BlossomHill Therapeutics, Inc.
$19.61HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Total return — ACRS vs BLSM
growth of $100 · dividends reinvested · last 1yACRS -28.6% (-28.6%/yr)BLSM +24.6% (+24.6%/yr)BLSM compounded faster over this window
ACRS BLSM
ACRS vs BLSM: by the numbers
- •ACRS is the larger company ($573M vs $570M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -921.50% net margin).
Metrics side by side
Valuation
| Metric | ACRS | BLSM |
|---|---|---|
| P/S ratio | 69.76 | N/A |
| P/B ratio | 4.60 | N/A |
Profitability
| Metric | ACRS | BLSM |
|---|---|---|
| Gross margin | 73.28% | 0.00% |
| Operating margin | -975.91% | 0.00% |
| Net margin | -921.50% | 0.00% |
| ROE | -60.79% | N/A |
| ROIC | -56.99% | -43.41% |
Growth (annualized)
| Metric | ACRS | BLSM |
|---|---|---|
| Revenue CAGR (5Y) | 4.39% | N/A |
| Total return CAGR (5Y) | -24.23% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.